DGEM-Leitlinie Enterale Ernährung: Diabetologie

Aktuelle Ernahrungsmedizin Klinik und Praxis

Volumn 28, Issue , 2003, Pages 103-109

  Goke B ^a   Hauner, H ^b   Toeller, M D ^b   Laube, H ^c   Lehnert, H ^d   Schrezenmeir, J ^e   Parhofer, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d Zentrum fur Innere Medizin der Univ   (Germany)

^e FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

carbohydrate metabolism; diabetes; Enteral nutrition

Indexed keywords

EID: 85025947723     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-36931     Document Type: Article

References (28)

1. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
2. Beaven K. Gastroparesis and jejunal feeding. J Ren Nutr 1999; 9: 202-205
3. Dowling CJ, Kumar S, Boulton JM et al. Severe gastroparesis diabeticorum in a young patient with insulin dependent diabetes. BMJ 1995; 310: 308-311
4. Devendra D, Millward BA, Travis SP. Diabetic gastroparesis improved by percutaneous endoscopic jejunostomy. Diabetes Care 2000; 23: 426-427
5. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 1996; 91: 2174-2178
6. Rabine JC, Barnett JL. Management ofthe patient with gastroparesis. J Clin Gastroenterol 2001; 32: 11-18
7. Shimizu H, Shimomura Y, Takahashi M, Kobayashi I, Tomizawa T, Kobayashi S. Enteral hyperalimentation with continuous subcutaneous insulin infusion improved severe diarrhea in poorly controlled diabetic patient. JPEN J Parenter Enteral Nutr 1991; 15: 181-183
8. van Heel DA, Levitt NS, Winter TA. Diabetic neuropathic cachexia: the importance ofpositive recognition and early nutritional support. Int J Clin Pract 1998; 52: 591-592
9. Ditesheim JA, Richards W, Sharp K. Fatal and disastrous complications following percutaneous endoscopic gastrostomy. Am Surg 1989; 55: 92-96
10. Taylor CA, Larson DE, Ballard DJ et al. Predictors ofoutcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc 1992; 67: 1042-1049
11. Kalliafas S, Choban PS, Ziegler D, Drago S, Flancbaum L. Erythromycin facilitates postpyloric placement of nasoduodenal feeding tubes in intensive care unit patients: randomized, double-blinded, placebo-controlled trial. JPEN J Parenter Enteral Nutr 1996; 20: 385-388
12. Kittinger JW, Sandler RS, Heizer WD. Efficacy of metoclopramide as an adjunct to duodenal placement of small-bore feeding tubes: a randomized, placebo-controlled, double-blind study. JPEN J Parenter Enteral Nutr 1987; 11: 33-37
13. Craig LD, Nicholson S, Silverstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 1998; 14: 529-534
14. McCargar LJ, Innis SM, Bowron E et al. Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM. Mol Cell Biochem 1998; 188: 81-89
15. Low CC, Grossman EB, Gumbiner B. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients. Diabetes 1996; 45: 569-575
16. Peters AL, Davidson MB, Isaac RM. Lack ofglucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med 1989; 87: 178-182
17. Peters AL, Davidson MB. Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. JPEN J Parenter Enteral Nutr 1992; 16: 69-74
18. Peters AL, Davidson MB. Addition ofhydrolyzed guar to enteral feeding products in type I diabetic patients. Diabetes Care 1996; 19: 899-900
19. Sanz-Paris A, Calvo L, Guallard A, Salazar I, Albero R. High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-pepti-de, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea. Nutrition 1998; 14: 840-845
20. Golay A, Schneider H, Bloise D, Vadas L, Assal JP. The effect of a liquid supplement containing guar gum and fructose on glucose tolerance in non-insulin-dependent diabetic patients. Nutr Metab Cardiovasc Dis 1995; 5: 141-148
21. Printz H, Recke B, Fehmann HC, Goke B. No apparent benefit of liquid formula diet in NIDDM. Exp Clin Endocrinol Diabetes 1997; 105: 134-139
22. Toeller M. Stellungnahme der Diabetes und Nutrition Study-Group (DNSG) ofthe European Association for the Study ofDiabetes (EASD) 2000 und des Ausschusses Ernährung der Deutschen Diabetes Gesellschaft. Ernährungsempfehlungen für Diabetiker 2000. Diabetes und Stoffwechsel 2000; 9: 241-246
23. Ha TK, Lean ME. Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr 1998; 52: 467-481
24. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Technical Review). Diabetes Care 2002; 25: 148-198
25. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Position Statement). Diabetes Care 2002; 25: 202-212
26. Deutsche Diabetes Gesellschaft. Stellungnahme der Deutschen Diabetes-Gesellschaft: Statement zu Zuckeraustauschstoffen. Diabetologie-Informationen 1999; 4: 314-316
27. Deutsche Diabetes Gesellschaft. Deutsche Evidenz-basierte Diabetes Leitlinien. Diskussionsentwurf. Diabetes und Stoffwechsel 1999; 8: 25-36
28. Stürmer W, Kasper H, Schrezenmeir J, Kramer E. Favorable glycemic effects of a new balanced liquid diet for enteral nutrition - results of a short-term study in 30 typ II diabetic patients. Clin Nutr 1994; 13: 221-227